One-pot sequential coupling reactions as a new practical protocol for the synthesis of unsymmetrical 2,3-diethynyl quinoxalines and 4-ethynyl-substituted pyrrolo[1,2-a]quinoxalines

[1]  B. Notash,et al.  New Pd-Mediated Cascade Reactions for Synthesis of Novel Functionalized 1,3-Oxazole-Linked Quinoxaline Amines , 2019, ChemistrySelect.

[2]  F. Rominger,et al.  N-Heterocycle-Fused Pentalenes by a Gold-Catalyzed Annulation of Diethynyl-Quinoxalines and -Phenazines. , 2018, Chemistry.

[3]  A. Yoshida,et al.  One-pot synthesis of biologically active 1,2,3-trisubstituted pyrrolo[2,3-b]quinoxalines through a palladium-catalyzed reaction with internal alkyne moieties , 2018, Molecular Diversity.

[4]  A. Yoshida,et al.  Regioselective synthesis of 2,3-disubstituted 1-alkyl pyrrolo[2,3-b] quinoxalines through palladium-catalyzed Heck reaction of chalcones and evaluation of their anti-bacterial activities , 2018 .

[5]  M. Nabid,et al.  Using Calcium Carbide as an Acetylene Source for Cascade Synthesis of Pyrrolo[2,3‐b]quinoxalines via Copper‐Free Sonogashira Coupling Reaction , 2018 .

[6]  H. A. Rudbari,et al.  Development of an unexpected reaction pathway for the synthesis of 1,2,4-trisubstituted pyrrolo[1,2-a]quinoxalines through palladium-catalyzed cascade reactions , 2017 .

[7]  F. Rominger,et al.  On the Gold-Catalyzed Generation of Vinyl Cations from 1,5-Diynes. , 2017, Angewandte Chemie.

[8]  A. Bamoniri,et al.  Efficient one-pot synthesis of new 1-amino substituted pyrrolo[1,2-a]quinoline-4-carboxylate esters via copper-free Sonogashira coupling reactions , 2017, Molecular Diversity.

[9]  M. Estève,et al.  Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives. , 2016, European journal of medicinal chemistry.

[10]  A. Bamoniri,et al.  Novel multi-component synthesis of 1,4-disubstituted pyrrolo[1,2-a]quinoxalines through palladium-catalyzed coupling reaction/hetero-annulation in water , 2016 .

[11]  A. Bamoniri,et al.  Synthesis of novel 1,5-disubstituted pyrrolo[1,2-a]quinazolines and their evaluation for anti-bacterial and anti-oxidant activities , 2016 .

[12]  Lei Feng,et al.  Efficient synthesis of pyrrolo[1,2-a]quinoxalines catalyzed by a Brønsted acid through cleavage of C-C bonds. , 2016, Organic & biomolecular chemistry.

[13]  A. Bamoniri,et al.  Efficient one-pot synthesis of new 1-amino substituted pyrrolo[1,2-a]quinoline-4-carboxylate esters via copper-free Sonogashira coupling reactions , 2016, Molecular diversity.

[14]  Ali Keivanloo,et al.  Efficient synthesis of 2-phenyl-3-substituted furo/thieno[2,3-b]quinoxalines via Sonogashira coupling reaction followed by iodocyclization and subsequent palladium-catalyzed cross-coupling reactions , 2016 .

[15]  M. Cordeiro,et al.  Quinoxaline, its derivatives and applications: A State of the Art review. , 2015, European journal of medicinal chemistry.

[16]  S. Jayaprakash,et al.  Simple and Highly Efficient Synthesis of Indolo- and Pyrrolo[1,2-a]quinoxalines Promoted by Molecular Iodine , 2015, Synlett.

[17]  M. A. Ezeokonkwo,et al.  Synthesis and Antibacterial Studies of Some Alkynylated Benzo[a]phenoxazin-5-one and 1,4-Naphthoquinone Derivatives , 2015 .

[18]  A. Caflisch,et al.  Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation. , 2014, Journal of medicinal chemistry.

[19]  H. Gali-Muhtasib,et al.  The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway , 2014, Molecular Cancer.

[20]  V. Thiéry,et al.  One-pot synthesis of pyrrolo[1,2-a]quinoxaline derivatives via iron-promoted aryl nitro reduction and aerobic oxidation of alcohols. , 2012, Organic letters.

[21]  A. Verma,et al.  Lewis Acid-Catalyzed Selective Synthesis of Diversely Substituted Indolo- and Pyrrolo[1,2-a]quinoxalines and Quinoxalinones by Modified Pictet–Spengler Reaction , 2011 .

[22]  G. Déléris,et al.  New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II. , 2011, European journal of medicinal chemistry.

[23]  E. Novellino,et al.  Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. , 2009, Journal of medicinal chemistry.

[24]  V. Sinou,et al.  New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity. , 2008, Bioorganic & medicinal chemistry.

[25]  E. Negishi,et al.  Efficient and stereoselective synthesis of yellow scale pheromone via alkyne haloboration, Zr-catalyzed asymmetric carboalumination of alkenes (ZACA reaction), and Pd-catalyzed tandem Negishi coupling. , 2008, Organic letters.

[26]  F. Pinguet,et al.  In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. , 2008, Bioorganic & medicinal chemistry.

[27]  C. Jarry,et al.  Synthesis of new pyrrolo[1,2-a]quinoxaline derivatives as potential inhibitors of Akt kinase. , 2008, Journal of enzyme inhibition and medicinal chemistry.

[28]  E. Novellino,et al.  Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. , 2005, Biochemistry.

[29]  S. Rault,et al.  Synthesis of New 2‐(Aminomethyl)‐4‐phenylpyrrolo[1,2‐a]‐quinoxalines and their Preliminary In‐vivo Central Dopamine Antagonist Activity Evaluation in Mice , 2000, The Journal of pharmacy and pharmacology.

[30]  E. Novellino,et al.  Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies. , 1999, Journal of medicinal chemistry.

[31]  R. David,et al.  Changing therapeutic paradigms in glaucoma management. , 1998, Expert opinion on investigational drugs.

[32]  M. Hamon,et al.  Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. , 1997, Journal of medicinal chemistry.

[33]  G. Adams,et al.  Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines. , 1993, Anti-cancer drug design.

[34]  J. Bergman,et al.  The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline. , 1991, Antiviral research.

[35]  D. E. Ames,et al.  Alkynyl- and dialkynyl-quinoxalines. Synthesis of condensed quinoxalines , 1980 .

[36]  Y. Tohda,et al.  A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines , 1975 .